AATC's Q2 revenues fall 2.20% y/y, but lower costs lift net income 9.30% as product sales grow and the company advances OptiVu and Analytics.
Zacks
More News
Autoscope's Valuation Remains Premium: Is It Worth Overpaying for?
AATC's OptiVu expansion and AI-driven traffic solutions support long-term growth, but premium valuation and margin pressure may limit its near-term appeal.
Zacks
Top Research Reports for Merck, Southern Company & Lumentum
Merck, Southern Company and Lumentum lead Zacks' featured research reports as growth drivers, expansion plans and key risks shape outlooks.
Zacks
Autoscope Q1 Earnings Decline Y/Y on Weak Product Sales
AATC's Q1 earnings fall y/y as weak product sales offset steady royalties, while the company continued investing in its OptiVu platform.
Zacks
Top Analyst Reports for Amazon, Intel & Applied Materials
Amazon drives gains with diverse revenue streams and AI push, but rising costs, debt, and fierce competition cloud its near-term outlook.
Zacks
Autoscope Q4 Earnings Fall Y/Y Amid Revenue Decline & Transition
AATC reports sharp declines in revenues and earnings as a product transition and inventory adjustments weigh on its Q4 performance.
Zacks
Top Analyst Reports for Visa, Charles Schwab & Amphenol
Analysts spotlight fresh insights on Visa, Schwab and Amphenol, with new data on growth drivers, risks and market performance.
Zacks
Autoscope Technologies Posts Q3 Loss, Sharp Y/Y Revenue Drop
AATC's Q3 results reflect a steep y/y revenue decline, a swing to a loss and transitional challenges as customers shift to the new OptiVu platform.
Zacks
Revisiting 5 Small Cap AI Stocks: Still Buys?
Mark Zinski, Zacks Small Cap Stock Analyst, returns to review AI stocks from prior podcast episodes.
Zacks
Autoscope Q2 Earnings Fall 50% Y/Y as Revenues Drop Amid Product Shift
AATC Q2 earnings plunge 50% y/y on lower royalties and sales, but management sees growth ahead with new product adoption and stable cost controls.